Record overview
Status and phase
Status: TERMINATED
Phase: PHASE2
Sponsor: ADC Therapeutics S.A.
Condition: Diffuse Large B-cell Lymphoma
NCT05144009
A Study of Loncastuximab Tesirine and Rituximab (Lonca-R) in Previously Untreated Unfit/Frail Participants With Diffuse Large B-cell Lymphoma (DLBCL)
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Registry Stop Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: rare_population_signal | strict_eligibility_signal
Stopped reason
Context when available
The benefit-risk profile does not support continuation of the LOTIS-9 trial.